Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Latest Articles
Submit an article Journal homepage
89
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients

Anna Piekarskaa Department of Infectious Diseases and Hepatology, Medical University of Lodz, Łódź, PolandCorrespondence[email protected]
View further author information
,
Aleksandra Berkan-Kawińskaa Department of Infectious Diseases and Hepatology, Medical University of Lodz, Łódź, PolandView further author information
,
Hanna Berakb Department for outpatients, Hospital for Infectious Diseases in Warsaw, Warsaw, PolandView further author information
,
Włodzimierz Mazurc Clinical Department of Infectious Diseases, Medical University of Silesia, Katowice, PolandView further author information
,
Marek Sitkod Department of Infectious and Tropical Diseases, Collegium Medicum, Jagiellonian University, Kraków, PolandView further author information
,
Anna Parfieniuk-Kowerdae Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, PolandView further author information
,
Beata Lorencf Department of Infectious Diseases, Pomeranian Center of Infectious Diseases, Medical University of Gdansk, Gdansk, PolandView further author information
,
Dorota Dybowskag Department of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University, Bydgoszcz, PolandView further author information
,
Ewa Janczewskah Department of Basic Medical Sciences, Faculty of Public Health, Medical University of Silesia, Katowice, PolandView further author information
,
Justyna Janocha-Litwini Department of Infectious Diseases and Hepatology, Wroclaw Medical University of Medicine, Wrocław, PolandView further author information
,
Beata Dobrackaj MedicalSpec Medical Center, Wrocław, PolandView further author information
,
Łukasz Sochak Department of Infectious, Tropical Diseases and Acquired Immunodeficiency, Pomeranian Medical University, Szczecin, PolandView further author information
,
Magdalena Tudrujek-Zdunekl Department of Infectious Diseases, Medical University of Lublin, Lublin, PolandView further author information
&
Robert Flisiake Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, PolandView further author information
 show all
Received 11 Oct 2023, Accepted 22 Mar 2024, Published online: 16 May 2024

References

  • Heffernan A, Cooke GS, Nayagam S, et al. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. Lancet. 2019;393(10178):1319–1329.
  • Zoratti MJ, Siddiqua A, Morassut RE, et al. Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: a systematic literature review and meta-analysis. Clinical Medicine. 2020;18:100237. doi: 10.1016/S0140-6736(18)32277-3
  • Maughan A, Sadigh K, Angulo-Diaz V, et al. Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients. BMC Infect Dis. 2019;19(1):378. doi: 10.1186/s12879-019-3974-7
  • Hull M, Shafran S, Wong A, et al. CIHR Canadian HIV trials network coinfection and concurrent diseases core research group: 2016 updated Canadian HIV/Hepatitis C adult guidelines for management and treatment. Can J Infect Dis Med Microbiol. 2016;2016:4385643. doi: 10.1155/2016/4385643
  • Piekarska A, Jabłonowska E, Garlicki A, et al. Real life results of direct acting antiviral therapy for HCV infection in HIV–hCV-coinfected patients: epi-Ter2 study. AIDS Care. 2020;32(6):762–769. doi: 10.1080/09540121.2019.1645808
  • http://www.pasl.pl/wp-content/uploads/2023/02/POL-Rekomendacje-HCV-2023-poprawione.pdf
  • European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C: final update of the series☆. J Hepatol. 2020;73(5):1170–1218. doi: 10.1016/j.jhep.2020.08.018
  • http://www.ptnaids.pl/images/pliki/zalecenia_2022_internet_OK.pdf
  • Younossi ZM, Stepanova M, Sulkowski M, et al. Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: the ASTRAL-5 study. Liver Int. 2017;37(12):1796–1804. doi: 10.1111/liv.13462
  • Gonzalez-Serna A, Corma-Gomez A, Tellez F, et al. Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice. J Antimicrob Chemother. 2023; dkad:278. 78(10):2591–2596. doi: 10.1093/jac/dkad278
  • Zarębska-Michaluk D, Jaroszewicz J, Parfieniuk-Kowerda A, et al. Pangenotypic and genotype-specific antivirals in the treatment of HCV genotype 4 infected patients with HCV monoinfection and HIV/HCV coinfection. J Clin Med. 2022;11(2):389. doi: 10.3390/jcm11020389
  • Genowska A, Zarębska-Michaluk D, Strukcinskiene B, et al. Changing epidemiological patterns of infection and mortality due to hepatitis C virus in Poland. J Clin Med. 2023;12(12):3922. doi: 10.3390/jcm12123922
  • Zeisel MB, Lupberger J, Fofana I, et al. Host-targeting agents for prevention and treatment of chronic hepatitis C – perspectives and challenges. J Hepatol. 2013;58(2):375–384. doi: 10.1016/j.jhep.2012.09.022
  • Zarębska-Michaluk D. Genotype 3-hepatitis C virus’ last line of defense. World J Gastroenterol. 2021;27(11):1006–1021. doi: 10.3748/wjg.v27.i11.1006
  • Kim HN, Nance RM, Williams-Nguyen JS, et al. Effectiveness of direct-acting antiviral therapy in patients with human immunodeficiency virus-hepatitis Cvirus coinfection in routine clinical care: amultimetrem study. Open Forum Infect Dis. 2019;6(4):ofz100. doi: 10.1093/ofid/ofz100. eCollection 2019 Apr.
  • Puoti M, Panzeri C, Rossotti R, et al. Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs. Dig Liver Dis. 2014;15:S206–11. doi: 10.1016/j.dld.2014.09.027
  • Zuckerman AD, Douglas A, Whelchel K, et al. Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: does coinfection really matter? PLOS ONE. 2019;14(11):e0225434. doi: 10.1371/journal.pone.0225434

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.